Imaging of musculoskeletal bacterial infections by [124I]FIAU-PET/CT.
Data(s) |
10/10/2007
|
---|---|
Identificador |
http://www.ncbi.nlm.nih.gov/pubmed/17925855 PLoS One, 2007, 2 (10), pp. e1007 - ? http://hdl.handle.net/10161/10369 1932-6203 |
Relação |
PLoS One 10.1371/journal.pone.0001007 |
Tipo |
Journal Article |
Cobertura |
United States |
Resumo |
BACKGROUND: Traditional imaging techniques for the localization and monitoring of bacterial infections, although reasonably sensitive, suffer from a lack of specificity. This is particularly true for musculoskeletal infections. Bacteria possess a thymidine kinase (TK) whose substrate specificity is distinct from that of the major human TK. The substrate specificity difference has been exploited to develop a new imaging technique that can detect the presence of viable bacteria. METHODOLOGY/PRINCIPAL FINDINGS: Eight subjects with suspected musculoskeletal infections and one healthy control were studied by a combination of [(124)I]FIAU-positron emission tomography and CT ([(124)I]FIAU-PET/CT). All patients with proven musculoskeletal infections demonstrated positive [(124)I]FIAU-PET/CT signals in the sites of concern at two hours after radiopharmaceutical administration. No adverse reactions with FIAU were observed. CONCLUSIONS/SIGNIFICANCE: [(124)I]FIAU-PET/CT is a promising new method for imaging bacterial infections. |
Formato |
e1007 - ? |
Idioma(s) |
ENG |
Palavras-Chave | #Arabinofuranosyluracil #Bacteria #Bacterial Infections #Bone and Bones #Case-Control Studies #Diagnostic Imaging #Humans #Muscles #Positron-Emission Tomography #Radiopharmaceuticals #Substrate Specificity #Thymidine Kinase #Tomography, X-Ray Computed |